The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline. The test, ...

The Food and Drug Administration (FDA) has cleared a new blood test designed to help diagnose Alzheimer's disease, which is expected to be available later this year. The blood test, known as ...

A new blood test developed through a collaboration between Roche Diagnostics and Eli Lilly and Co. has received clearance from the U.S. Food and Drug Administration. The plasma biomarker test called ...

The test, Elecsys pTau217, is a biomarker blood test that can help doctors identify patients who are likely or unlikely to have Alzheimer's-related brain changes, Roche said on Monday. Sign up here.

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd ...

The FDA cleared the Elecsys Phospho-Tau (217P) Plasma blood test, which Roche and Lilly say is the single-biomarker blood test designed to test for the likelihood of amyloid pathology, a brain symptom ...